PL2753187T3 - Sposób zapobiegania i/lub leczenia insulinooporności - Google Patents

Sposób zapobiegania i/lub leczenia insulinooporności

Info

Publication number
PL2753187T3
PL2753187T3 PL12758652T PL12758652T PL2753187T3 PL 2753187 T3 PL2753187 T3 PL 2753187T3 PL 12758652 T PL12758652 T PL 12758652T PL 12758652 T PL12758652 T PL 12758652T PL 2753187 T3 PL2753187 T3 PL 2753187T3
Authority
PL
Poland
Prior art keywords
preventing
insulin resistance
treating insulin
treating
resistance
Prior art date
Application number
PL12758652T
Other languages
English (en)
Other versions
PL2753187T5 (pl
Inventor
Max NIEUWDORP
Willem Meindert De Vos
Original Assignee
Acad Medisch Centrum
Caelus Pharmaceuticals B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47756609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2753187(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Acad Medisch Centrum, Caelus Pharmaceuticals B V filed Critical Acad Medisch Centrum
Publication of PL2753187T3 publication Critical patent/PL2753187T3/pl
Publication of PL2753187T5 publication Critical patent/PL2753187T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
PL12758652.7T 2011-08-30 2012-08-30 Sposób zapobiegania i/lub leczenia insulinooporności PL2753187T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161528931P 2011-08-30 2011-08-30
NL2007319 2011-08-30
PCT/NL2012/050592 WO2013032328A1 (en) 2011-08-30 2012-08-30 Method for preventing and/or treating insulin resistance
EP12758652.7A EP2753187B2 (en) 2011-08-30 2012-08-30 Method for preventing and/or treating insulin resistance

Publications (2)

Publication Number Publication Date
PL2753187T3 true PL2753187T3 (pl) 2019-05-31
PL2753187T5 PL2753187T5 (pl) 2026-02-09

Family

ID=47756609

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12758652.7T PL2753187T5 (pl) 2011-08-30 2012-08-30 Sposób zapobiegania i/lub leczenia insulinooporności

Country Status (13)

Country Link
US (2) US9433650B2 (pl)
EP (1) EP2753187B2 (pl)
JP (1) JP6116568B2 (pl)
KR (1) KR101982491B1 (pl)
CN (1) CN104244733B (pl)
AU (1) AU2012302364B2 (pl)
BR (1) BR112014004890A8 (pl)
CA (1) CA2851602C (pl)
DK (1) DK2753187T4 (pl)
PL (1) PL2753187T5 (pl)
RU (1) RU2613322C2 (pl)
SG (1) SG11201401811WA (pl)
WO (1) WO2013032328A1 (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2851602C (en) 2011-08-30 2020-07-14 Academisch Medisch Centrum Method for preventing and/or treating insulin resistance
IN2014DN07752A (pl) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
MX2015006491A (es) 2012-11-23 2015-12-03 Seres Health Inc Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
EP2951283A4 (en) 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Compositions and methods
MX369877B (es) 2013-02-04 2019-11-25 Seres Therapeutics Inc Composiciones y metodos.
JP2016519664A (ja) 2013-03-15 2016-07-07 セレス セラピューティクス インコーポレイテッド ネットワークを基にした微生物組成物及び方法
WO2015013214A2 (en) 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment
MX367109B (es) 2013-11-25 2019-08-05 Seres Therapeutics Inc Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
PL3242957T3 (pl) 2015-01-09 2020-10-05 Wageningen Universiteit Kompozycje zawierające bakterie i sposoby ich wykorzystania do leczenia i/lub zapobiegania chorobom żołądkowo-jelitowym, metabolicznym i/lub innym
JP2019500035A (ja) * 2015-12-31 2019-01-10 カエルス ファーマシューティカルズ ビー．ヴィ． ユーバクテリウム・ハリー（Ｅｕｂａｃｔｅｒｉｕｍ ｈａｌｌｉｉ）を培養し、保存する方法
CN106974939B (zh) * 2016-01-15 2020-08-25 深圳华大生命科学研究院 厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用
US10799558B2 (en) 2016-02-02 2020-10-13 Oncoimmune, Inc. Use of CD24 proteins for treating leptin-deficient conditions
WO2017146580A1 (en) 2016-02-25 2017-08-31 Caelus Pharmaceuticals B.V. Compositions and methods for preventing and/or treating vitamin b12 deficiency
CA3020454A1 (en) 2016-04-11 2017-10-19 Wageningen Universiteit Akkermansia glycaniphilus strains
AU2017324510B2 (en) 2016-09-07 2023-08-31 Temple University - Of The Commonwealth System Of Higher Education Compositions and methods for treatment of insulin resistance
WO2018134361A1 (en) * 2017-01-19 2018-07-26 Pleonova Ab Autologous fecal sample for use in the treatment of microbial dysbiosis
BR112020002992A2 (pt) 2017-08-14 2020-08-18 Seres Therapeutics, Inc. composições e métodos para tratamento de doença colestática
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
JP2021501185A (ja) 2017-10-30 2021-01-14 セレス セラピューティクス インコーポレイテッド 抗生物質耐性を処置するための組成物及び方法
JP7175990B2 (ja) * 2018-03-02 2022-11-21 アカデミッシュ メディッシュ セントラム 自己免疫疾患の予防または処置のための糞便物質
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
US12144834B2 (en) 2018-09-13 2024-11-19 Xbiome Inc. Methods and compositions for treating gastrointestinal and inflammatory disorders
CN113853198A (zh) 2019-04-09 2021-12-28 德慕拜昂生物科技公司 用于改善皮肤健康和用于治疗和预防与病原微生物相关联的疾病、疾患和病症的组合物和方法
CN114502720A (zh) 2019-08-14 2022-05-13 瓦格宁根大学 包含myo-肌醇至丙酸途径的细菌
NL2024569B1 (en) 2019-12-24 2021-09-06 Univ Wageningen Bacterium comprising myo-inositol to propionate pathway
RU2734336C1 (ru) * 2020-03-27 2020-10-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ ранней неинвазивной диагностики метаболических нарушений у детей и подростков
TW202206062A (zh) 2020-04-24 2022-02-16 美國坦普大學 高等教育聯邦系統 治療非酒精性脂肪肝炎的方法
JP2023545458A (ja) * 2020-10-14 2023-10-30 ダームビオント インコーポレイテッド 皮膚の健康状態の改善、ならびに、真菌および他の病原性マイクローブに関連する疾患、障害および疾病の処置および予防のための組成物および方法
CN113604400B (zh) * 2021-08-26 2023-06-02 王玉莹 具有预防或治疗糖尿病作用的新型乳杆菌yuyingw
NL2036594B1 (en) 2023-12-20 2025-07-04 Univ Wageningen Bacterium comprising phytate-degradation pathway

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
SI0796623T1 (en) * 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US6227863B1 (en) 1998-02-18 2001-05-08 Donald Spector Phonics training computer system for teaching spelling and reading
US6224863B1 (en) * 1998-10-30 2001-05-01 University Of South Carolina Antibiotic composition from alcaligenes species and method for making and using the same
EP1228769A1 (de) * 2001-02-02 2002-08-07 Jörg-Peter Prof. Schür Symbiontisches Regenerativum
JP4307006B2 (ja) * 2002-03-28 2009-08-05 キリンフードテック株式会社 糖尿病予防剤
BR0312936B8 (pt) † 2002-07-18 2021-07-27 Agricultural Research Council aditivo alimentício, método para melhorar desempenho de ruminantes, bem como método de isolamento de uma cultura biologicamente pura de um micro-organismo ruminal superior
GB0307026D0 (en) * 2003-03-27 2003-04-30 Rowett Res Inst Bacterial supplement
BRPI0519174A2 (pt) † 2004-12-22 2008-12-30 Michigan Biotech Inst cepa recombinante de um microorganismo produtor de Ácido succÍnico, mÉtodo para produzir Ácido succÍnico, molÉcula de dna, plasmÍdeo de dna, e, cÉlula hospedeira
US20080069861A1 (en) * 2006-09-19 2008-03-20 National Starch And Chemical Investment Holding Corporation Probiotic/Non-Probiotic Combinations
WO2008076696A2 (en) * 2006-12-18 2008-06-26 Washington University In St. Louis The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
JP5350626B2 (ja) * 2007-12-20 2013-11-27 キリンフードテック株式会社 樹状細胞活性化用組成物
US20110189149A1 (en) † 2008-06-20 2011-08-04 Remy Burcelin New Uses of Lactic Acid Bacteria and Bifidobacteria
WO2010036876A2 (en) * 2008-09-25 2010-04-01 New York University Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
BRPI1007312A2 (pt) * 2009-01-23 2020-08-18 Kadant Inc. sistemas e métodos para fornecimento de desempenho aperfeiçoado na desidratação em uma máquina de fabricação de papel.
US20120027737A1 (en) † 2009-03-25 2012-02-02 Chr-Hansen A/S Use of probiotics to ameliorate diet-induced insulin resistance
CA2776420A1 (en) * 2009-10-05 2011-04-14 Aak Patent B.V. Methods for diagnosing irritable bowel syndrome
WO2011145516A1 (ja) 2010-05-18 2011-11-24 エイブル株式会社 メタン生成の抑制方法
WO2012142605A1 (en) 2011-04-15 2012-10-18 Samaritan Health Services Rapid recolonization deployment agent
CA2851602C (en) 2011-08-30 2020-07-14 Academisch Medisch Centrum Method for preventing and/or treating insulin resistance
JP2019500035A (ja) † 2015-12-31 2019-01-10 カエルス ファーマシューティカルズ ビー．ヴィ． ユーバクテリウム・ハリー（Ｅｕｂａｃｔｅｒｉｕｍ ｈａｌｌｉｉ）を培養し、保存する方法

Also Published As

Publication number Publication date
KR101982491B1 (ko) 2019-05-27
CN104244733B (zh) 2017-07-28
US9623055B2 (en) 2017-04-18
PL2753187T5 (pl) 2026-02-09
CA2851602C (en) 2020-07-14
SG11201401811WA (en) 2014-09-26
CA2851602A1 (en) 2013-03-07
US20160317589A1 (en) 2016-11-03
KR20140128936A (ko) 2014-11-06
AU2012302364A1 (en) 2014-04-17
WO2013032328A1 (en) 2013-03-07
CN104244733A (zh) 2014-12-24
RU2613322C2 (ru) 2017-03-15
BR112014004890A2 (pt) 2017-03-21
DK2753187T3 (en) 2019-01-28
BR112014004890A8 (pt) 2018-02-06
EP2753187B2 (en) 2025-08-06
US20140294774A1 (en) 2014-10-02
US9433650B2 (en) 2016-09-06
JP6116568B2 (ja) 2017-04-19
EP2753187A1 (en) 2014-07-16
RU2014112223A (ru) 2015-10-10
JP2014527068A (ja) 2014-10-09
DK2753187T4 (da) 2025-10-20
AU2012302364B2 (en) 2016-07-28
EP2753187B1 (en) 2018-10-24

Similar Documents

Publication Publication Date Title
SG11201401811WA (en) Method for preventing and/or treating insulin resistance
BR112014000238A2 (pt) método e artigo
PL2739268T3 (pl) Sposób i formulacja do inhalacji
EP2580009A4 (en) BIMETALLIC COMPONENT AND METHOD THEREFOR
BR112014010450A2 (pt) composição e método
BR112013029226A2 (pt) método de cimentação e fluído curável
DK2911727T3 (da) Fremgangsmåde til fremstilling af et brugsklart kateter og en katetersamling til anvendelse i nævnte fremgangsmåde
BR112013001592A2 (pt) artigo e método
SG11201504022RA (en) Glutamase inhibitors and method of use
EP2756517A4 (en) COLD PLASMA PROCESSING DEVICES AND ASSOCIATED METHODS
FI20116190L (fi) Hissijärjestely ja menetelmä
EP2812344A4 (en) SUBSTRATES, PEPTIDE NETWORKS AND METHODS
BR112013010847A2 (pt) artigo e método
BR112013016641A2 (pt) artigo e método
EP2871040A4 (en) WELDING METHOD AND WELDING CONNECTION
BR112014005660A2 (pt) implantes revestidos e métodos relacionados
BR112014011685A2 (pt) composto, utilização de um composto e método
BR112014001973A2 (pt) composto e método de tratamento do câncer em um sujeito
HUE063599T2 (hu) Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére
EP2749948A4 (en) INTERFERENCE CONTROL DEVICE AND METHOD
TWI562386B (en) Resistance change device and manufacturing method of resistance change device
DK3604562T3 (da) Fremgangsmåde og stålkomponent
EP2868742A4 (en) FILTRATION MEMBRANE AND FILTRATION PROCESS
IL231094A0 (en) Fish anesthetic and method
IT1399157B1 (it) Rivestimento autolubrificante e metodo